1037P Phase I Dose-Escalation Trial with Tumor-Targeted Interleukin-12 (IL12-L19L19) in Patients with Solid Tumors
ANNALS OF ONCOLOGY(2023)
Key words
Cancer Immunotherapy
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined